Literature DB >> 29128403

Cln5 is secreted and functions as a glycoside hydrolase in Dictyostelium.

Robert J Huber1, Sabateeshan Mathavarajah2.   

Abstract

Ceroid lipofuscinosis neuronal 5 (CLN5) is a member of a family of proteins that are linked to neuronal ceroid lipofuscinosis (NCL). This devastating neurological disorder, known commonly as Batten disease, affects all ages and ethnicities and is currently incurable. The precise function of CLN5, like many of the NCL proteins, remains to be elucidated. In this study, we report the localization, molecular function, and interactome of Cln5, the CLN5 homolog in the social amoeba Dictyostelium discoideum. Residues that are glycosylated in human CLN5 are conserved in the Dictyostelium homolog as are residues that are mutated in patients with CLN5 disease. Dictyostelium Cln5 contains a putative signal peptide for secretion and we show that the protein is secreted during growth and starvation. We also reveal that both Dictyostelium Cln5 and human CLN5 are glycoside hydrolases, providing the first evidence in any system linking a molecular function to CLN5. Finally, immunoprecipitation coupled with mass spectrometry identified 61 proteins that interact with Cln5 in Dictyostelium. Of the 61 proteins, 67% localize to the extracellular space, 28% to intracellular vesicles, and 20% to lysosomes. A GO term enrichment analysis revealed that a majority of the interacting proteins are involved in metabolism, catabolism, proteolysis, and hydrolysis, and include other NCL-like proteins (e.g., Tpp1/Cln2, cathepsin D/Cln10, cathepsin F/Cln13) as well as proteins linked to Cln3 function in Dictyostelium (e.g., AprA, CfaD, CadA). In total, this work reveals a CLN5 homolog in Dictyostelium and further establishes this organism as a complementary model system for studying the functions of proteins linked to NCL in humans.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Batten disease; CLN5; Dictyostelium discoideum; Glycoside hydrolase; Neuronal ceroid lipofuscinosis; Secretion

Mesh:

Substances:

Year:  2017        PMID: 29128403     DOI: 10.1016/j.cellsig.2017.11.001

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  22 in total

Review 1.  Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.

Authors:  Konrad Kaminiów; Sylwia Kozak; Justyna Paprocka
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

2.  Lysosomal Proteomics Links Disturbances in Lipid Homeostasis and Sphingolipid Metabolism to CLN5 Disease.

Authors:  Stefano Doccini; Maria Marchese; Federica Morani; Nicola Gammaldi; Serena Mero; Francesco Pezzini; Rabah Soliymani; Melissa Santi; Giovanni Signore; Asahi Ogi; Silvia Rocchiccioli; Katja M Kanninen; Alessandro Simonati; Maciej M Lalowski; Filippo M Santorelli
Journal:  Cells       Date:  2022-06-04       Impact factor: 7.666

Review 3.  Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.

Authors:  Wenping Li; Stephanie M Cologna
Journal:  Mol Omics       Date:  2022-05-11

4.  Longitudinal In Vivo Monitoring of the CNS Demonstrates the Efficacy of Gene Therapy in a Sheep Model of CLN5 Batten Disease.

Authors:  Nadia L Mitchell; Katharina N Russell; Martin P Wellby; Hollie E Wicky; Lucia Schoderboeck; Graham K Barrell; Tracy R Melzer; Steven J Gray; Stephanie M Hughes; David N Palmer
Journal:  Mol Ther       Date:  2018-07-17       Impact factor: 11.454

Review 5.  Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.

Authors:  Yasir H Qureshi; Penelope Baez; Christiane Reitz
Journal:  Mol Cell Biol       Date:  2020-09-14       Impact factor: 4.272

6.  Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation.

Authors:  Tatyana Danyukova; Khandsuren Ariunbat; Melanie Thelen; Nahal Brocke-Ahmadinejad; Sara E Mole; Stephan Storch
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

7.  Novel likely disease-causing CLN5 variants identified in Pakistani patients with neuronal ceroid lipofuscinosis.

Authors:  Beenish Azad; Stephanie Efthymiou; Tipu Sultan; Marcello Scala; Javeria Raza Alvi; Caroline Neuray; Natalia Dominik; Asma Gul; Henry Houlden
Journal:  J Neurol Sci       Date:  2020-04-07       Impact factor: 3.181

8.  Autophagy-lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease.

Authors:  Jessie Adams; Melissa Feuerborn; Joshua A Molina; Alexa R Wilden; Babita Adhikari; Theodore Budden; Stella Y Lee
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

9.  Aberrant Autophagy Impacts Growth and Multicellular Development in a Dictyostelium Knockout Model of CLN5 Disease.

Authors:  Meagan D McLaren; Sabateeshan Mathavarajah; William D Kim; Shyong Q Yap; Robert J Huber
Journal:  Front Cell Dev Biol       Date:  2021-07-05

Review 10.  Cellular models of Batten disease.

Authors:  Christopher J Minnis; Christopher D Thornton; Lorna M FitzPatrick; Tristan R McKay
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-10-23       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.